Bioregenx (BRGX) Interest Expenses (2023 - 2026)

Bioregenx's Interest Expenses history runs 4 years deep, the most recent figure standing at $77086.0 for Q1 2026.

• In Q1 2026, Interest Expenses rose 3.83% year-over-year to $77086.0; the TTM figure through Mar 2026 stood at $302425.0 (up 3.61% YoY), while the FY2025 annual figure was $299578.0, up 3.07% from the prior year.
• Interest Expenses was $77086.0 for Q1 2026 at Bioregenx, down from $82147.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $83756.0 in Q4 2024 to a low of $45193.0 in Q4 2023.
• Historically, Interest Expenses has averaged $66044.4 across 4 years, with a median of $71086.0 in 2025.
• The sharpest annual moves came in 2024 and 2025: Interest Expenses jumped 85.33% in 2024, then retreated 1.92% in 2025.
• A 4-year view of Interest Expenses shows it stood at $45193.0 in 2023, then surged by 85.33% to $83756.0 in 2024, then declined by 1.92% to $82147.0 in 2025, then retreated by 6.16% to $77086.0 in 2026.
• The last three Interest Expenses figures came in at $77086.0 (Q1 2026), $82147.0 (Q4 2025), and $72106.0 (Q3 2025), per Business Quant data.